Kiora Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (KPRX) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2024 to Q4 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Symbol
KPRX on Nasdaq
Shares outstanding
3,938,449
Price per share
$1.97
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
616,169
Total reported value
$1,714,712
% of total 13F portfolios
0%
Share change
-315,674
Value change
-$910,085
Number of holders
17
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Kiora Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (KPRX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ADAR1 Capital Management, LLC 9.9% $1,029,805 365,179 ADAR1 Capital Management GP, LLC 30 Jun 2025
Nantahala Capital Management, LLC 10% 0% $949,288 +$149,944 363,712 +19% Nantahala Capital Management, LLC 30 Sep 2025
HIRSCHMAN ORIN 4.9% -40% $380,178 -$123,265 192,984 -24% Orin Hirschman 31 Dec 2025
Nantahala Capital Partners Limited Partnership 5.3% $534,968 189,705 NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP 08 Aug 2025
Alyeska Investment Group, L.P. 2.5% $197,389 75,628 Alyeska Investment Group, L.P. 31 Dec 2024
GOLDMAN SACHS GROUP INC 0% $339 130 THE GOLDMAN SACHS GROUP, INC. 31 Dec 2024

As of 30 Sep 2025, 17 institutional investors reported holding 616,169 shares of Kiora Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (KPRX). This represents 16% of the company’s total 3,938,449 outstanding shares.

Top 21 Institutional Shareholders

The largest institutional shareholders of Kiora Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (KPRX) together control 16% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
ADAR1 Capital Management, LLC 4.3% 167,941 +0.5% 0.05% $466,876
Nantahala Capital Management, LLC 4% 156,427 -26% 0.03% $434,867
Stonepine Capital Management, LLC 3.6% 140,598 -21% 0.32% $390,862
CITADEL ADVISORS LLC 1.1% 44,573 0% $124,804
DRW Securities, LLC 0.94% 36,865 0.01% $102,484
VANGUARD GROUP INC 0.53% 20,915 0% $58,562
GEODE CAPITAL MANAGEMENT, LLC 0.48% 18,853 +1.5% 0% $52,787
RENAISSANCE TECHNOLOGIES LLC 0.31% 12,400 0% $34,472
TWO SIGMA INVESTMENTS, LP 0.3% 11,984 0% $33,316
CITIGROUP INC 0.1% 3,884 +10997% 0% $10,875
UBS Group AG 0.03% 1,364 -92% 0% $3,792
SBI Securities Co., Ltd. 0.01% 256 0% 0% $712
BlackRock, Inc. 0% 58 0% 0% $161
BANK OF AMERICA CORP /DE/ 0% 25 +19% 0% $70
NewEdge Advisors, LLC 0% 22 0% 0% $61
Activest Wealth Management 0% 2 0% 0% $6
OSAIC HOLDINGS, INC. 0% 2 0% 0% $5
RAYMOND JAMES FINANCIAL INC 0% 0 -100% $0
AIGH Capital Management LLC 0% 0 -100% $0
Tower Research Capital LLC (TRC) 0% 0 -100% $0
Velan Capital Investment Management LP 0% 0 -100% $0

Institutional Holders of Kiora Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (KPRX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 35,261 $69,464 +$25,066 $1.97 5
2025 Q3 616,169 $1,714,712 -$910,085 $2.78 17
2025 Q2 931,843 $2,683,707 -$1,054,952 $2.88 16
2025 Q1 1,285,403 $3,869,063 +$78,079 $3.01 18
2024 Q4 1,259,460 $4,164,086 +$76,851 $3.30 16
2024 Q3 1,213,569 $4,441,661 +$905,961 $3.66 18
2024 Q2 966,044 $4,057,360 +$4,057,359 $4.20 15